Dynamic Technology Lab Private Ltd Invests $171,000 in agilon health, inc. (NYSE:AGL)

Dynamic Technology Lab Private Ltd purchased a new stake in agilon health, inc. (NYSE:AGL) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 43,481 shares of the company’s stock, valued at approximately $171,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in AGL. Citigroup Inc. grew its position in shares of agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the period. AQR Capital Management LLC raised its position in shares of agilon health by 3,338.5% during the 2nd quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter. Bank of New York Mellon Corp lifted its stake in agilon health by 18.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,108,921 shares of the company’s stock valued at $7,252,000 after buying an additional 174,883 shares in the last quarter. Susquehanna Fundamental Investments LLC boosted its holdings in agilon health by 65.0% in the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company’s stock worth $5,262,000 after buying an additional 316,856 shares during the last quarter. Finally, Rhumbline Advisers increased its stake in agilon health by 24.3% during the 2nd quarter. Rhumbline Advisers now owns 433,019 shares of the company’s stock worth $2,832,000 after buying an additional 84,573 shares in the last quarter.

Insider Activity at agilon health

In related news, CEO Steven Sell bought 20,000 shares of the company’s stock in a transaction that occurred on Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares of the company’s stock, valued at approximately $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. 3.20% of the stock is owned by insiders.

Analysts Set New Price Targets

AGL has been the topic of several research reports. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a report on Wednesday, October 2nd. Royal Bank of Canada reaffirmed an “outperform” rating and set a $3.00 target price on shares of agilon health in a report on Tuesday, November 19th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Finally, Benchmark reaffirmed a “buy” rating and set a $9.00 price objective on shares of agilon health in a research note on Thursday, August 8th. Three analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $6.05.

agilon health Trading Up 10.3 %

AGL opened at $2.31 on Tuesday. The stock has a market capitalization of $949.70 million, a PE ratio of -2.36 and a beta of 0.60. agilon health, inc. has a one year low of $1.50 and a one year high of $13.76. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The business’s 50 day moving average price is $2.73 and its 200 day moving average price is $4.63.

agilon health (NYSE:AGL) last posted its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The business had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the prior year, the firm earned ($0.06) EPS. As a group, equities research analysts expect that agilon health, inc. will post -0.47 EPS for the current year.

agilon health Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.